OptInterim: Optimal Two and Three Stage Designs for Single-Arm and Two-Arm Randomized Controlled Trials with a Long-Term Binary Endpoint

Optimal two and three stage designs monitoring time-to-event endpoints at a specified timepoint

AuthorBo Huang <bo.huang@pfizer.com> and Neal Thomas <neal.thomas@pfizer.com>
Date of publication2012-12-12 20:39:06
MaintainerBo Huang <bo.huang@pfizer.com>
LicenseGPL (>= 2)

View on CRAN

Questions? Problems? Suggestions? or email at ian@mutexlabs.com.

All documentation is copyright its authors; we didn't write any of that.